Jian-jong T. Liang
No. 128, Academia Road
Nankang District, TPQ 11529, Taiwan
Nankang District, TPQ 11529, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 43 publications
Zika virus impairs non-homologous end joining and exacerbates DNA damage in neural progenitors derived from Huntington's disease iPSCs via mutant huntingtin-elicited Ku70/Ku80 complex disruption.
Journal: Stem cell research & therapy
Published: April 05, 2025
AAV-mediated delivery of a broadly neutralizing anti-flavivirus antibody protects against dengue and Zika viruses in a mouse model.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 27, 2025
Corrigendum to "Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin" [Biochem. Pharmacol. 215 (2023) 115688].
Journal: Biochemical pharmacology
Published: January 18, 2025
Correction: Development of a Humanized Antibody with High Therapeutic Potential against Dengue Virus Type 2.
Journal: PLoS neglected tropical diseases
Published: March 13, 2024
Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody.
Journal: JCI insight
Published: January 24, 2024
Human ACE2 protein is a molecular switch controlling the mode of SARS-CoV-2 transmission.
Journal: Journal of biomedical science
Published: May 15, 2023
Development of AAV-delivered broadly neutralizing anti-human ACE2 antibodies against SARS-CoV-2 variants.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: May 04, 2023
Natural fucoidans inhibit coronaviruses by targeting viral spike protein and host cell furin.
Journal: Biochemical pharmacology
Published: March 27, 2023
Correction: Lee et al. The Synergistic Inhibition of Coronavirus Replication and Induced Cytokine Production by Ciclesonide and the Tylophorine-Based Compound Dbq33b. Pharmaceutics 2022, 14, 1511.
Journal: Pharmaceutics
Published: December 13, 2022
A receptor-binding domain-based nanoparticle vaccine elicits durable neutralizing antibody responses against SARS-CoV-2 and variants of concern.
Journal: Emerging microbes & infections
Published: November 17, 2022
Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
Journal: Journal of medical virology
Published: August 29, 2022
Longitudinal neutralizing antibody responses after SARS-CoV-2 infection: A convalescent cohort study in Taiwan.
Journal: Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi
Published: August 01, 2022
Last Updated: 09/26/2026